Potential drug targets of SARS-CoV-2: From genomics to therapeutics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
Authors
Keywords
Severe acute respiratory syndrome coronavirus-2, Coronavirus disease 19, Drug targets
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 177, Issue -, Pages 1-9
Publisher
Elsevier BV
Online
2021-02-10
DOI
10.1016/j.ijbiomac.2021.02.071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
- (2020) Zhixin Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Genomic Characterization and Phylogenetic Classification of Bovine Coronaviruses Through Whole Genome Sequence Analysis
- (2020) Tohru Suzuki et al. Viruses-Basel
- Regulation of the ER Stress Response by the Ion Channel Activity of the Infectious Bronchitis Coronavirus Envelope Protein Modulates Virion Release, Apoptosis, Viral Fitness, and Pathogenesis
- (2020) Shumin Li et al. Frontiers in Microbiology
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19
- (2020) Anas Shamsi et al. BIOSCIENCE REPORTS
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs
- (2020) Sayeed ur Rehman et al. CLINICAL SCIENCE
- IS TEICOPLANIN A COMPLEMENTARY TREATMENT OPTION FOR COVID-19? THE QUESTION REMAINS
- (2020) Giancarlo Ceccarelli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- COVID‐19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients
- (2020) Chiranjib Chakraborty et al. JOURNAL OF MEDICAL VIROLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- SARS Coronavirus Redux
- (2020) Enya Qing et al. TRENDS IN IMMUNOLOGY
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- Coronavirus membrane fusion mechanism offers a potential target for antiviral development
- (2020) Tiffany Tang et al. ANTIVIRAL RESEARCH
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Potential diagnostics and therapeutic approaches in COVID-19
- (2020) Pratibha Kumari et al. CLINICA CHIMICA ACTA
- COVID-19: Drug Targets and Potential Treatments
- (2020) Carmen Gil et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy
- (2020) Taj Mohammad et al. VIRUS RESEARCH
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
- (2020) Ahmad Abu Turab Naqvi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin
- (2020) Urooj Fatima et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
- (2020) Vinit Raj et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection
- (2019) Naoko Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Global Epidemiology of Bat Coronaviruses
- (2019) Antonio Wong et al. Viruses-Basel
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
- (2019) Alexandra C. Walls et al. CELL
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
- (2019) Robert N. Kirchdoerfer et al. Nature Communications
- Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
- (2018) Jian Lei et al. ANTIVIRAL RESEARCH
- Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
- (2017) Alexandra C. Walls et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
- (2017) Xufang Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
- (2017) Yuan Yuan et al. Nature Communications
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism
- (2016) Yi Wang et al. mBio
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
- (2014) Jose L. Nieto-Torres et al. PLoS Pathogens
- Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge
- (2013) Carmina Verdiá-Báguena et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”
- (2013) Jasper Fuk-Woo Chan et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity
- (2013) Christopher C. Stobart et al. JOURNAL OF VIROLOGY
- Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids
- (2012) Carmina Verdiá-Báguena et al. VIROLOGY
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension
- (2011) Aartjan J.W. te Velthuis et al. NUCLEIC ACIDS RESEARCH
- Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex
- (2011) Yu Chen et al. PLoS Pathogens
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- SARS coronavirus replicase proteins in pathogenesis
- (2007) Rachel L. Graham et al. VIRUS RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started